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Background: Projection analyses can provide estimates of the future health burden of increasing BMI and
represent a relevant and useful tool for public health planning. Our study presents long-term (2013–2030) projections
of the prevalence and numbers of individuals by BMI category for adult men and women in Quebec. Three applications
of projections to estimate outcomes more directly pertinent to public health planning, as well as an in-depth discussion
of limits, are provided with the aim of encouraging greater use of projection analyses by public health officers.
Methods: The weighted compositional regression method is applied to prevalence time series derived from sixteen
cross-sectional survey cycles, for scenarios of linear change and deceleration. Estimation of the component of projected
change potentially amenable to intervention, future health targets and the projected impact on type 2 diabetes,
were done.
Results: Obesity prevalence in Quebec is projected to rise steadily from 2013 to 2030 in both men (from 18.0-19.4% to
22.2-30.4%) and women (from 15.5-16.3% to 18.2-22.4%). Corresponding projected numbers of obese individuals are
(579,000-625,000 to 790,000-1,084,000) in men and (514,000-543,000 to 661,000-816,000) in women. These projected
increases are found to be primarily an ‘epidemiologic’ rather than ‘demographic’ phenomenon and thus potentially
amenable to public health intervention. Assessment of obesity targets for 2020 illustrates the necessity of using
projected rather than current prevalence; for example a targeted 2% drop in obesity prevalence relative to 2013
translates into a 3.6-5.4% drop relative to 2020 projected levels. Type 2 diabetes is projected to increase from 6.9% to
9.2-10.1% in men and from 5.7% to 7.1-7.5% in women, from 2011–2012 to 2030. A substantial proportion of this
change (25-44% for men, and 27-43% for women) is attributable to the changing BMI distribution.
Conclusions: Obesity in Quebec is projected to increase and should therefore continue to be a public health priority.
Application of projections to estimate the proportion of change potentially amenable to intervention, feasible health
targets, and future chronic disease prevalence are demonstrated. Projection analyses have limitations, but represent a
pertinent tool for public health planning.
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The prevalence of obesity in Quebec (the second most
populous province of Canada, with an estimated population
of 8,067,319 in 2013) has seen a continuous increase
over at least the past 2.5 decades [1,2], mirroring
trends in developed countries around the world [3].
From 1987 to 2012 for example, the prevalence of
(self-report) obesity in Quebec adults more than doubled
in value from ≈ 8% to 17%. These trends indicate a
growing health and economic burden, as elevated BMI is
associated with a range of co-morbidities and increased
mortality [4-7].
Projection analyses of obesity have been done with
increasing frequency in recognition of the need to estimate
the future magnitude of this public health issue, and thus
to plan health services, programs and interventions [8-13].
Projection studies however are not standard surveillance
tools used by public health officers, and are largely the pur-
view of university research scientists who may have differ-
ent aims and perspectives. The objective of the current
study is thus to provide projection analyses of BMI preva-
lence for the Quebec adult population, with the aim of
informing and supporting public health planning. Short-
term (2012–2019) projections using simple linear
regression [12] represent the only other known projection
study of Quebec obesity trends. Our study provides
long-term (2013–2030) projections using a weighted
compositional approach that overcomes methodological
shortcomings of simple linear regression that may lead to
bias and inaccuracy [10].
One issue that may limit the adoption of projection
analyses for public health planning is that public health
professionals may not be aware of the ways in which
projections can be applied to estimate outcomes more
directly related to policy and programs. To address this
issue, three methodological techniques by which BMI
prevalence projections can be translated into more
concrete measures for health planning are demonstrated:
(1) the separation of the projected time trends into demo-
graphic and epidemiologic components and thus
estimation of the component potentially amenable to
intervention, (2) use of projections in the planning of
health targets including metrics that measure the difficulty
of achieving targets as well as the consequences of not
achieving them, and (3) the estimation of the projected
impact on chronic disease using type 2 diabetes as an
example, including estimation of the proportion of
diabetes prevalence change potentially amenable to
intervention.
Finally, projections may be perceived as technical and
abstract mathematical constructs that are far removed from
the multi-faceted (e.g. social, cultural, and technological)
and complex nature of real-world public health issues. Thus
we also provide a detailed discussion of the major limitsand assumptions of the scenarios that underlie the BMI
projections and suggest ways in which the results can be
interpreted.
Methods
Data sources and variables
BMI prevalence time series were constructed from available
cross-sectional surveys that measured self-report height and
weight, and were representative of the Quebec population
of adults 18 years of age and over. All surveys excluded the
northern health regions of Nunavik and Terre-Cries-de-la-
Baie-James. Sixteen independent survey cycles spanning the
years from 1987 to 2012 were identified. These included
four survey types: the Quebec Health Survey or ESQ (1987)
[14] and the Quebec Health and Social Survey or
ESS (1992–1993, 1998) [15] which were conducted
by the Quebec Statistics Institute, and the National
Population Health Survey or NPHS (1994–1995,
1996–1997, 1998–1999) [16] and the Canadian Com-
munity Health Survey or CCHS (2000–2001, 2002,
2003, 2005, 2007, 2008, 2009, 2010, 2011, 2012)
[17,18] which were conducted by Statistics Canada. A
description of each survey cycle, including name of
survey, corresponding year, and sample size is provided in
Table 1. Survey data and values were extracted from
master files for all cycles.
For each survey cycle, individual-level BMI was calcu-
lated as the weight in kilograms divided by the square of
the height in meters; women that were pregnant at the
time of the survey were excluded. Continuous BMI
values were then classified into 4 categories according
to standard WHO categorization [6]: Underweight
(BMI < 18.5), Normal (18.5 ≤ BMI < 25), Overweight
(25 ≤ BMI < 30), and Obese (BMI ≥ 30). The prevalence
of each BMI category was calculated for 4 categories
of age (18–24, 25–44, 45–64, 65+) and by sex. Variances
and covariances were estimated using bootstrap (estima-
tions from NPHS and CCHS) or Taylor linearization
(estimations from ESQ and ESS) methods that accounted
for the complex design of the surveys [19-21]. A total of
128 age, sex and time point combinations were available
for analysis. Of these, 12 combinations were excluded: six
due to missingness in the BMI variable that exceeded
10% [22] and six due to their imprecision or small
cell counts and the diffusion rules of the statistical
agencies that managed the surveys [23,24].
Historical time series of the Quebec population by age
and sex, as well as official population projections used in
BMI projections and secondary analyses, were obtained
from the Quebec Statistics Institute [25]. For projections
of the impact of BMI on type 2 diabetes (T2D), esti-
mates of the prevalence of T2D by BMI category, age
group and sex were obtained from the CCHS, Cycle
2011–2012.
Table 1 Description of the 16 survey cycles used to construct the BMI time series
Year Name of survey Abbr. Sample size** Source
1 1987 Quebec Health Survey ESQ 17,494 Quebec Statistics Institute
2 1992-1993 Quebec Health and Social Survey ESS 21,563 Quebec Statistics Institute
3 1994-1995 National Population Health Survey NPHS 2,304 Statistics Canada
4 1996-1997 National Population Health Survey NPHS 2,218 Quebec Statistics Institute
5 1998 Quebec Health and Social Survey ESS 18,779 Statistics Canada
6 1998-1999 National Population Health Survey NPHS 2,326 Statistics Canada
7 2000-2001 Canadian Community Health Survey CCHS 20,161 Statistics Canada
8 2002 Canadian Community Health Survey* CCHS 4,581 Statistics Canada
9 2003 Canadian Community Health Survey CCHS 24,789 Statistics Canada
10 2005 Canadian Community Health Survey CCHS 26,633 Statistics Canada
11 2007 Canadian Community Health Survey CCHS 10,802 Statistics Canada
12 2008 Canadian Community Health Survey CCHS 10,735 Statistics Canada
13 2009 Canadian Community Health Survey CCHS 10,216 Statistics Canada
14 2010 Canadian Community Health Survey CCHS 10,214 Statistics Canada
15 2011 Canadian Community Health Survey CCHS 10,548 Statistics Canada
16 2012 Canadian Community Health Survey CCHS 10,588 Statistics Canada
*Corresponds to Cycle 1.2: Mental Health and Wellbeing.
**Sample Size corresponds to individuals 18+ years of age, from Quebec, with valid BMI.
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BMI category, 2013–2030
Regression is a frequently used approach in BMI and
obesity projections [8-10,12], and represents an accessible
and intuitive way to model and project trends in
cross-sectional survey time series. Of the many re-
gression approaches that have been used, we consider
the compositional approach [10,26] to be the most
statistically valid for the projection of BMI prevalence.
In this approach, the set of prevalences corresponding
to the four BMI (i) categories, for specified age (j)
and sex (k), Pjk tð Þ ¼ Pijk tð Þ; i ¼ 0…3
 
, are transformed
and projected together, accounting for the multinomial
nature of Pjk tð Þ. Proper modeling of the above characteris-
tics in prevalence time series is essential to reduce bias and
inaccuracy that can become sizeable especially for longer
term projection horizons [10]. We have further extended
the compositional approach to account for the heterogen-
eity in survey variance structure, by including a weighting
effect of the covariance matrix of Pjk tð Þ from each survey
cycle. Prediction intervals to assess statistical variability,
and goodness of fit were also estimated. Technical details
of the method including sensitivity analyses can be found in
Additional files 1 and 2.
Two scenarios are projected. In the first scenario,
linear time trends are fitted to the transformed prevalence,
and are assumed to continue into the future; the assump-
tion of linear trends is considered a default model that is
most often used in the projection literature. In the second
scenario, logarithmic trends are fitted and assumed tocontinue into the future. This model has been considered
in recent projection analyses to account for possible future
stabilization in US and European obesity trends [8,27].
These two scenarios were considered reasonable based on
the scientific literature. The ‘linear’ scenario is considered
‘pessimistic’ since it results in a roughly linear continuation
of the increasing obesity prevalence observed in all age and
sex categories, while the logarithmic model is considered
an ‘optimistic’ or ‘deceleration’ scenario as it projects a
future decrease in the rate of change of historical trends,
leading to a diminution of the rate of obesity increase.
Corresponding projected numbers of individuals by
BMI (i), age (j) and sex (k) are obtained by the product of
projected prevalence and projected population estimates:
Nijk(t) = Pijk(t)njk(t), where Nijk(t) and Pijk(t) are the pro-
jected numbers and prevalence respectively, and njk(t)
represents the projected population by age and
sex category. The age aggregated number of individuals
Nik(t) is equal to the sum of numbers over all age
groups: Nik tð Þ ¼
X4
j¼1
Nijk tð Þ , while the age aggregated
prevalence Pik(t) is equal to Nik(t) divided by the corre-
sponding population: Pik(t) =Nik(t)/nk(t). Nik(t) can be inter-
preted as a measure of the absolute burden, while Pik(t) is a
measure of the BMI distribution in the Quebec population.
The principle results of the projection analysis thus com-
prise PLINik tð Þ;NLINik tð Þ and PDECik tð Þ; NDECik tð Þ which are the
prevalence and number of individuals for the linear and
deceleration scenarios respectively.
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contributions
Temporal change in the projected prevalence and number
of individuals can be approximately decomposed into two
components: a demographic effect which represents the
contribution of changes in population age structure, and
an epidemiologic effect which represents the contribution
of changes in age- and sex-specific BMI prevalence
which are independent of population age structure.
This decomposition is informative as the epidemiologic
effect can be interpreted as the component of change
that is potentially amenable to intervention while the
demographic effect (i.e. the effect of population aging)
cannot in general be modified. In practice, any actual inter-
ventions are highly unlikely to eliminate the epidemio-
logical effect completely, and so this effect represents a
hypothetical maximum. The separation of the demographic
effect from overall trends is especially pertinent in the case
of Quebec (as well as other developed nations) in which
there is a strong demographic shift to an older population
age structure, which can drive a range of health issues.
The demographic contributions to age aggregated preva-
lence and numbers (Pdemoik tð Þ;Ndemoik tð Þ ) are first estimated
by holding age and sex specific BMI prevalences fixed at a
reference level, Pijk(tref), while allowing only the population
to evolve. The epidemiologic contribution is then estimated
by subtracting the demographic effect from the overall trend
and thus effectively represents the contribution attributable
to other risk factors. Thus Pepiik tð Þ ¼ Pik tð Þ−Pdemoik tð Þ and
Nepiik tð Þ ¼ Nik tð Þ−Ndemoik tð Þ . Nepiik tð Þ is of particular interest
as it can be interpreted as the number of cases of obesity
that are potentially amenable to interventions that target
the population BMI distribution. For this reason, Nepiik tð Þ
will be termed the number of ‘avoidable cases’.
In the current study, demographic and epidemiologic
changes in obesity trends are estimated relative to
two reference times: (1) tref = 2011 − 2012 in order to
estimate the proportion of future projected changes in
obesity prevalence potentially amenable to intervention
(the aggregate of two cycles is implemented here to ensure
adequate precision in the prevalence estimates), and (2)
tref = 1987 in order to estimate obesity prevalence under
the hypothetical scenario that the BMI distribution ‘returns’
to past levels.
Planning of future health targets
The application of projections to the planning of health
targets will be shown by the quantitative assessment of
three hypothetical targets for 2020 (using a planning
date of 2013) in the context of projected trends. The
hypothetical future targets comprise: (1) a 2% reduction
in prevalence relative to 2013 estimated values, (2) a target
that holds obesity prevalence constant and equal to 2013values and (3) a 2% reduction in obesity prevalence
relative to 2020 projected values.
Three quantitative measures will be applied in the
assessments: (1) The gap or difference between target
and projected prevalence, ΔPTP, which measures the
difficulty of achieving a future target, (2) the average
annual rate of change in prevalence (AACTP) to achieve a
target, which is a measure of the yearly effort required to
change projected trends; and (3) the difference between
target and projected numbers of individuals ΔNTP, which
represents a measure of the consequence in terms of
population burden, of not achieving the targets.Projected impact on type 2 diabetes
The expected increase in the prevalence of numerous
co-morbidities (type 2 diabetes, hypertension, incapacity,
etc.) represents a primary public health concern associated
with rising obesity levels [28,29]. Projection analyses
of BMI can be applied to estimate the magnitude of
increase in associated co-morbidity prevalence, which
will be demonstrated using type 2 diabetes (T2D). The
projected number of cases of T2D by BMI, age and sex
(ηijk(t)), is estimated as the product of the estimated preva-
lence of T2D in each BMI, age and sex category (πijk) with
the corresponding projected numbers of individuals:
ηijk(t) = πijk ×Nijk(t). Aggregation over BMI and age cat-
egories is then done to obtain total projected num-
bers of cases ðηk tð Þ ¼
X
i;j
πijk  Nijk tð ÞÞ and prevalence
ðπk tð Þ ¼ 1nk tð Þ
X
i;j
πijk  Nijk tð ÞÞ by sex, where nk(t) rep-
resents the projected population by sex. A basic as-
sumption in this estimation is that the BMI, age and
sex specific prevalence of T2D (πijk) is held fixed and
not in itself projected; for the present analysis πijk is
estimated from the pooled 2011–2012 CCHS cycles.
ηk(t) and πk(t) thus represent the projected chronic
disease numbers and prevalence respectively where
the age, sex and BMI specific T2D prevalence profile
remains constant but the BMI distribution and popu-
lation evolve, and can be interpreted as a measure of the
projected combined impact of BMI epidemiology and
population demographics. Estimation of the epidemiologic
contribution to ηk(t) and πk(t) can be done as before
(Additional file 3, Section A3.1 describes this calculation
in greater detail).Results and discussion
Projections of prevalence and numbers by BMI category,
2013–2030
Projection results showing fitted and projected age
aggregated prevalence are shown in Figure 1a to h for
men and women. The ‘pessimistic’ linear scenario PLINik tð Þ
 
















































































































Figure 1 Projections (2013 to 2030) of age-aggregated prevalence by BMI category, for men and women. The linear scenario is indicated
by the black line, the deceleration scenario is indicated by the gray line, and the historical BMI time series data are indicated by the open circles.
Lo et al. BMC Public Health 2014, 14:996 Page 5 of 14
http://www.biomedcentral.com/1471-2458/14/996is represented by the black line and the ‘optimistic’
deceleration scenario PDECik tð Þ
 
is represented by the
gray line; the range of possible future outcomes can
be interpreted as falling between the span of the two
scenarios [30,31]. Values representing age aggregated sur-
vey time series data are indicated by the circles. Pro-
jected prevalence values are listed in Table 2a and b for
the years 2013, 2020 and 2030.
As can be seen, obesity prevalence is projected to
rise steadily from 2013 to 2030 for both scenarios in
both men (18.0-19.4% to 22.2-30.4%) and women
(15.5-16.3% to 18.2-22.4%). Here, and for the results
that follow, a reported range in values corresponds tothe projection results of the deceleration (optimistic)
and linear (pessimistic) scenarios respectively. These
projections translate to 23-57% and 17-37% proportional
increases in prevalence for men and women respectively.
Prevalence of overweight (Figure 1c and d) are projected
to remain fairly stable for men (40.8-40.6% to 40.7-38.6%)
and to increase slowly for women before also stabiliz-
ing (27.5-27.8% to 29.4-30.6%). Normal weight prevalence
(Figure 1e and f) is projected to decrease steadily in both
men (40.0-38.9% to 36.0-30.1%) and women (52.9-51.9%
to 49.0-44.2%). Finally the prevalence of underweight
(Figure 1g and h) is projected to decrease in both
men (1.2-1.2% to 1.1-0.9%) and women (4.1-3.9% to
Table 2 Projected prevalence by BMI class for the years
2013, 2020 and 2030 for (a) Men and (b) Women; pairs of
values represent the range spanned by the deceleration
and linear scenarios respectively
Men: Projected Prevalence by BMI Class
Year Underweight Normal Overweight Obese
2013 1.2% - 1.2% 40.0% - 38.9% 40.8% - 40.6% 18.0% - 19.4%
2020 1.1% - 1.0% 37.9% - 35.1% 41.0% - 40.2% 19.9% - 23.7%
2030 1.1% - 0.9% 36.0% - 30.1% 40.7% - 38.6% 22.2% - 30.4%
Women: Projected Prevalence by BMI Class
Year Underweight Normal Overweight Obese
2013 4.1% - 3.9% 52.9% - 51.9% 27.5% - 27.8% 15.5% - 16.3%
2020 3.7% - 3.4% 51.0% - 48.6% 28.4% - 29.1% 16.8% - 18.9%
2030 3.4% - 2.7% 49.0% - 44.2% 29.4% - 30.6% 18.2% - 22.4%
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is high.
Fitted and projected trends are quite similar between
men and women though absolute levels of prevalence
for obesity and overweight are higher for men vs.
women, and absolute levels of prevalence for normal
weight and underweight are lower for men vs. women.
Trends in the two scenarios are also similar, with abso-
lute rates of change being attenuated in the deceleration
scenario as compared with the linear scenario. These
trends are found to be similar and consistent across all
age categories (Additional file 4).
Projected age aggregated numbers of individuals, NLINik
tð Þ and NDECik tð Þ, are shown in Figure 2a and b for men
and women. Projected values are also listed in Table 3a
and b for the years 2013, 2020 and 2030. The projected
trends in the number of individuals are similar to those
for prevalence with an additional increasing trend due
to the overall increase in total population projected
from 2013 to 2030 (Column 2 of Table 3a and b). In
particular, the number of obese individuals is projected to
rise steadily from 2013 to 2030 for both scenarios and for
both men (579,000-625,000 to 790,000-1,084,000) and
women (514,000-543,000 to 661,000-816,000), while the
number of overweight individuals (Figure 2c and d) are
projected to increase slowly for men (1,315,000-1,308,000
to 1,451,000-1,376,000) and for women (913,000-923,000
to 1,071,000-1,114,000).
The projected substantial and continued increase in
obesity prevalence for Quebec are in line with other pro-
jection studies done for Canada [12,32,33], the USA
[8,34], UK [10,35,36] and Australia [36] for a projection
horizon up to 20 years and using a range of methods.
In particular, projected prevalences are similar to
short-term (2012–2019) projection results made using
simple linear regression on CCHS data [12], the only other
known projection study of Quebec BMI trends. Theseoverall trends in prevalence indicate that the population
BMI distribution is shifting to the right as well as
supporting observations from other studies that indi-
cate a widening and increasing skew [10,33,36,37].
Visual assessments indicate good fit of both linear and
log models to measured data in both age aggregated and
age specific results and projected trends are seen to be
smooth extensions of clear historical trends (cf. Figure 1
and Additional file 4). Goodness of fit for obesity prevalence
is further confirmed using the R2 statistic (adapted for GLS)
which yields values ranging from 0.44-0.97 for age and sex
specific trends (Additional file 2). Prediction intervals
(shown in Additional file 2: Figure A2) indicate that
the fitted models are statistically stable, though these
intervals should not be interpreted as uncertainty bounds
(cf Discussion). Finally, sensitivity analyses using a recent
(2000–2012) subset of the measured data show that
projected trends are robust (Additional file 2: Figure A2).
Overall, the projection analyses indicate that obesity
will represent a growing health burden on the Quebec
population, and public health challenge. These results
are statistically robust; however they are based on the
chosen scenarios and on the assumption that current
trends will continue into the future.Separation of epidemiologic and demographic
contributions
Estimated demographic and epidemiologic contributions to
projected change are shown in Figure 3. The demographic
effect in prevalence

Pdemoobese; k tref ¼ 2011‐2012
 
, where age
and sex specific prevalences have been fixed at 2011–
2012 values are shown by the dotted lines in Figure 3a
and b for men and women respectively. It can be seen
that Pdemoobese; k tref ¼ 2011‐2012
 
appears flat and unchanged
from the 2011–2012 obesity prevalence, indicating that
demographic changes plays virtually no role in the projected
obesity trends. As a result, the projected increase in obesity
prevalence is almost purely an epidemiologic phenomenon
and thus is in principle potentially amenable to intervention.
This is further shown by plots of the epidemiologic effect
Pepiobese; k tref ¼ 2011‐2012
 
which are represented as
black and gray circles; the points are closely coincident
with the corresponding linear and deceleration scenarios.
The demographic effect is expected to contribute slightly
to the number of obese individuals (Figure 3c and d); this is
due to the dependence of Ndemoobese; k tref ¼ 2011‐2012
 
on not
only the age structure but the total population size which is
projected to increase (Table 3). As a result, epidemiologic
effects, shown by the black and gray circles, account for
most but not all of the projected increase in obesity num-
bers. Calculated values of Nepiobese; k tref ¼ 2011‐2012
 
for
the two scenarios indicate approximately 76,000-202,000












































































































































































Figure 2 Projections (2013 to 2030) of age-aggregated numbers of individuals by BMI category, for men and women. The linear scenario is
indicated by the black line, the deceleration scenario is indicated by the gray line, and the historical BMI time series data are indicated by the open circles.
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by 2020 for men and women respectively, due to changes
in BMI epidemiology; these represent the number of avoid-
able cases of obesity as defined earlier. These numbers in-
crease to 163,000-456,000 and 70,000-225,000 by 2030 for
men and women respectively.
The demographic effect in prevalence Pdemoobese;k tref ¼ 1987
 
,
where age and sex specific prevalences have been
fixed at 1987 values are shown by the dashed lines in
Figure 3. Pdemoobese;k tref ¼ 1987
 
remains virtually un-
changed from the fitted 1987 obesity prevalence; the
epidemiologic contributions are not shown but follow thetotal projected trends closely. This result suggests that if
the population BMI distribution could somehow be
returned to that of 1987, the overall obesity prevalence
would return to 1987 levels as well, in spite of changes in
population age structure that have occurred since then.
Ndemoobese;k tref ¼ 1987
 
is projected to increase slightly in
both men and women. Calculated values of Nepiobese;k
tref ¼ 1987
 
represent the number of avoidable cases
of obesity should the BMI distribution return to that of
1987. By 2013, the first projection year, it is estimated that
approximately 321,000-367,000 and 203,000-232,000 obese
men and women were accrued due to changes in the BMI
Table 3 Projected numbers of individuals by BMI class for the years 2013, 2020 and 2030 for (a) Men and (b) Women;
pairs of values represent the range spanned by the deceleration and linear scenarios respectively
Men: Projected Numbers by BMI Class
Year Adult Population Underweight Normal Overweight Obese
2013 3,225,000 39,000 – 38,000 1,291,000 – 1,254,000 1,315,000 – 1,308,000 579,000 – 625,000
2020 3,376,000 38,000 – 35,000 1,281,000 – 1,183,000 1,383,000 – 1,358,000 673,000 – 799,000
2030 3,563,000 39,000 – 31,000 1,283,000 – 1,072,000 1,451,000 – 1,376,000 790,000 – 1,084,000
Women: Projected Numbers by BMI Class
Year Adult Population Underweight Normal Overweight Obese
2013 3,321,000 136,000 – 131,000 1,757,000 – 1,682,000 913,000 – 923,000 514,000 – 543,000
2020 3,459,000 129,000 – 117,000 1,765,000 – 1,682,000 984,000 – 1,008,000 580,000 – 652,000
2030 3,640,000 125,000 – 100,000 1,783,000 – 1,610,000 1,071,000 – 1,114,000 661,000 – 816,000
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able cases of obesity is projected to reach 509,345-803,000
and 322,000-477,000 men and women, relative to 1987.
In the present study, it is shown that projected changes
in obesity are almost completely an epidemiologic effect.
Thus future increases in obesity prevalence and numbers
could in principle be eliminated if increases in age specific
obesity prevalence were to be halted. These analyses
suggest that holding the population BMI distribution
constant at 2011–2012 levels or ‘returning’ the BMI
distribution to 1987 levels could both be considered
as concrete and beneficial intervention benchmarks.Figure 3 Separation of epidemiologic and demographic contributions
individuals, for men and women. The linear scenario is indicated by the
The demographic projection using 2011–2012 as reference is indicated by
indicated by the black and gray circles. The demographic projection usingPlanning of future health targets
Figure 4a-c shows the three hypothetical obesity
prevalence targets for the time period 2013–2020,
with projections over this period from both scenarios
superimposed. In Figure 4a, a targeted decrease in
obesity prevalence of 2% for 2020 relative to 2013 estimated
levels is compared to projected trends. Achievement of this
target would require a substantial deviation (ΔPTP = − 3.6
to − 5.4%) relative to projections and an average annual
change (AACTP) of −0.52 to −0.77%; the number of obese
individuals (ΔNTP) would be reduced by an estimated
249,000-370,000. Figure 4b shows a more modest targetto the projected change in obesity prevalence and numbers of
black line and the deceleration scenario is indicated by the gray line.
the dotted line; the corresponding epidemiologic projections are
1987 as reference is indicated by the dashed line.
Figure 4 Three hypothetical future obesity targets are shown, superimposed on projected trends. In each graph, the black line indicates
the linear scenario and the black dotted arrow indicates the corresponding target relative to the projection. The gray line indicates the deceleration
scenario and the gray dotted arrow indicates the corresponding target. Numbers to the right of each graph indicate the difference between targeted
and projected prevalence (ΔPTP) for the linear (black) and deceleration (gray) scenarios respectively.
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Achievement of this target would nevertheless still require
a deviation ΔPTP = −1.6 to −3.4% from projected
trends, and an AACTP of −0.23 to −0.49%; an estimated
(ΔNTP) = 112,000 − 233,000 obese individuals could be
avoided. Finally, Figure 4c shows a target based on a 2%
decrease in obesity prevalence relative to projected values
for 2020. In this case, the required deviation from
projected trends is specified by the target itself to be at
ΔPTP = 2% and is associated with an AACTP of −0.29% per
year. The projected 2020 obesity prevalence should this
target be achieved is 16.3-19.2% and includes the possibility
of an increase in prevalence from 2013. Achieving this
target would reduce the projected number of obese individ-
uals by an estimated 137,000 for both scenarios.
The application of quantitative techniques, including
the use of projections, has been advocated in the health
policy literature [38,39] for the planning of feasible
health targets. The estimation of the gap between target
and projected prevalence (ΔPTP) and the average annual
rate of change required (AACTP) in the current study
demonstrates the necessity to assess targets based on
future projected prevalence corresponding to the target
date, rather than prevalence levels at the start or planning
date. For example, the targeted 2% reduction in obesity
prevalence relative to 2013 shown in Figure 4a is represen-
tative of the kind of targets implemented in public health
programs worldwide, where efforts are typically announced
to improve on current health levels [40,41]. However as
shown, the difficulty of achieving this target becomes
greatly amplified (to a 3.6-5.4% prevalence reduction), when
compared with projected trends, which likely represents a
more accurate and realistic measure. Use of the projected
prevalence as a point of reference thus correctly accounts
for the additional effect of time trends that need to becountered in order to achieve targets. Estimation of the
consequence of not achieving targets is considered an
essential element in target planning and evaluation [42];
projections permit estimation of the number of avoidable
cases of obesity, ΔNTP, which represents one such measure.
More generally, the planning of feasible health targets could
be further improved by the integration of quantitative pro-
jections with the estimated impact of available intervention
programmes, an area of ongoing research.
Projected impact on type 2 diabetes
The estimated BMI and age specific T2D prevalences
(πijk) for 2011–2012 show marked increasing trends with
both BMI and age in men and women (Additional file 3:
Figure A3.1). Projections of age aggregated T2D prevalence
are shown in Figure 5 for (a) men and (b) women. T2D
prevalence in adult men, estimated at ≈ 6.9% in 2011–2012,
is projected to increase to 7.9-8.3% by 2020, and to
9.2-10.1% by 2030, due to combined BMI and demographic
effects. T2D prevalence in women, estimated at ≈ 5.7% in
2011–2012, is projected to increase to 6.3-6.5% by 2020,
and to 7.1-7.5% by 2030.
The black and gray circles represent the epidemiologic
contribution (since 2011–2012) estimated by the two
projection scenarios. In particular, for men the epide-
miologic component of change ðπepik¼1 tð ÞÞ is estimated
to be ≈ 0.6-1.4% in 2030, or to contribute ≈ 25-44% of
the total projected increase in T2D prevalence relative to
2011–2012. This corresponds to ≈ 20,000-49,000 avoidable
cases. For women πepik¼2 tð Þ is estimated to be ≈ 0.4-0.8%, or
to contribute ≈ 27-43% of the total projected increase,
corresponding to ≈ 14,000-29,000 avoidable cases. Results
thus indicate that increasing BMI and aging of the Quebec
population will likely combine to drive projected future
increases in overall T2D prevalence. Estimation of the
Figure 5 Projections of the impact of BMI on type 2 diabetes prevalence. The linear scenario is indicated by the black line and the deceleration
scenario is indicated by the gray line. The demographic projection using 2011–2012 as reference is indicated by the dotted line; the corresponding
epidemiologic projections are indicated by the black and gray circles.
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that a substantial component of the projected change
will in principle be amenable to interventions that act
on the BMI distribution of the population.
The projection analyses of T2D make the basic assump-
tion that the prevalence of T2D by age, sex and BMI
categories will remain constant in time. In reality this as-
sumption will not hold due to temporal change in T2D
epidemiology as well as the dependence of T2D preva-
lence at a given moment in time on the cumulative effect
of past trends. Nevertheless, this kind of projection pro-
vides useful insight into the evolution of disease burden
for public health planning, and similar estimations have
been implemented in other studies [35,43]. For example,
the projection estimates can be interpreted as a baseline
or counterfactual scenarios on which further hypotheses
or scenarios (related to specified changes to the T2D
prevalence profile) could be based. Alternatively they
could be interpreted as a hypothetical scenario where the
current T2D prevalence profile were to be applied to a fu-
ture population (with corresponding future BMI and
population structure). An internal validation study in fact
suggests that πijk is fairly stable in time, and that the pro-
jections of T2D may represent reasonable though slightly
conservative future estimates (data not shown).
Limitations and interpretation of projection results
Examination and discussion of the major assumptions,
limitations as well as strengths underlying the projection
analyses are next provided, with the aim of guiding their
interpretation and use for public health planning.
Scenarios vs. projections
A key concept in the interpretation and evaluation of
projection analyses is that they can be thought of asquantitative expressions of underlying qualitative scenarios.
Scenarios are non-quantitative, non-probabilistic, plausible
portraits of alternative futures; they can be considered as
ensembles of diverse assumptions, and are typically formu-
lated by expert opinion [31,44,45]. Thus while projection
analyses are themselves mathematically rigorous, their
validity depends in fact on the largely qualitative choice of
underlying scenario. In the current study, scenarios con-
sisted of the linear and deceleration models which are the
predominant models in the obesity projection literature
and were also deemed most plausible; as well, they
appeared reasonable based on the observed trends in the
historical data. The accuracy of these scenario choices with
respect to the actual future is inherently unquantifiable
however; a public health planner may either agree or
disagree with the scenarios chosen, and this will determine
the perceived accuracy or reliability of the results.
Uncertainty and prediction intervals
Prediction intervals are known to greatly underestimate
the actual error when applied to projection analyses
[46,47]. This is because prediction intervals account for
the statistical error due to data variability and estimation,
but do not account for the error in scenario choice which
can be thought of as model misspecification. For this
reason, the values spanned by the range of pertinent
scenarios are often used as a way to reasonably gauge
the uncertainty in projections [30,31]. In the current study
for example, while prediction intervals show that the pro-
jection models are statistically stable, the linear and
deceleration scenarios are used as reasonable bounds on
actual future BMI trends. Overall it should be emphasized
that projection results should not be interpreted as
infallible forecasts, but rather as estimates whose
Lo et al. BMC Public Health 2014, 14:996 Page 11 of 14
http://www.biomedcentral.com/1471-2458/14/996uncertainty depends on both statistical variability and on
the perceived validity of underlying scenarios.
The extrapolation assumption
All projections that make use of historical data make the
‘extrapolation assumption’ that past trends in these data
will continue into the future. In the current study time
trends in BMI are modelled using a period (or calendar
time) effect to essentially represent in an aggregate manner,
the effect of all causative factors over time (including the
effects of lifestyle habits such as diet and exercise, medical
and activity-reducing technology, food prices etc.). The
assumption that these trends will continue into the future
is not unreasonable given that population BMI is affected
by a diversity of factors whose aggregate effect is likely to
vary smoothly and slowly in the future, as they have done
so in the past. In light of the ‘extrapolation assumption’,
projection analyses can be interpreted as being baseline
trends that could represent upper/lower or pessimistic/
optimistic limits to actual trends, depending on shifts in
external causative factors that might be hypothesized to
occur. Alternatively, deviations in actual trends from
projections could be retrospectively interpreted as evi-
dence that changes in causative effects have occurred
and in particular, provide evidence for the efficacy of
interventions [48,49].
Cohort effects
Cohort effects were not modeled explicitly in the current
projection analysis as the restricted length relative to hu-
man lifetimes, and irregular spacing of the measured time
series data prevented reliable estimation for projection pur-
poses. The error induced by the absence of a cohort effect
in projections is not expected to be substantial however.
Age-period-cohort analyses have shown that period effects
(as represented by the time variable in our regression
model) represent the dominant contribution to obesity
trends [50-52]. One interpretation of the current projection
scenarios is that they represent a neutral middle ground be-
tween the positive cohort effects detected by some studies
[50,53], and the negative effects detected by others [54].
Alternatively, if recent Quebec cohorts are believed to
have increased obesity prevalence, obesity projection re-
sults can be interpreted as conservative underestimates;
on the other hand, if recent cohorts are believed to have
reduced obesity due to Quebec programs that have tar-
geted children and youth for example [55], the projec-
tions could be considered pessimistic overestimates.
Interpretation of Epidemiologic Effects
In our analysis we present a decomposition of demographic
and epidemiologic effects. It should be noted that our inter-
pretation of demographic effects is restricted to variations
in the BMI of sex and age groups in the adult Québecpopulation. As well, there are other largely unalterable
biological factors not taken into account in our analysis
which may influence BMI (e.g., hormonal factors, genetics)
[56]. It is furthermore unknown to what extent the
epidemiologic effects are truly amenable due to the
complex interaction of biological, behavioral and environ-
mental factors on individual-level body weight [56]. Thus
the epidemiological effect should be interpreted as an
approximate and hypothetical upper limit to what might
be potentially amenable to public health intervention.
Self-report BMI
Self-report BMI is known to underestimate measured
BMI [57], though the two measures are highly correlated
[58,59]. The use of self-report BMI in the present study,
reflects a limitation in the available data, as Quebec-level
surveys with measured BMI do not exist in sufficient num-
bers to form time series that can be projected reliably. Cor-
rection equations for self-report BMI have been proposed
[60,61]. However as the magnitude of the correction is
known to vary with both time [62] and survey-specific char-
acteristics [63], the accuracy of these equations outside of
the particular survey cycles for which they were developed is
uncertain [62,64]. Thus it was felt that application of a global
correction factor over the diverse surveys that comprise the
historical time series could result in additional random as
well as systematic error in both the BMI values and their
time trend. The only published estimate of the magnitude
of self-report bias in Quebec is from the 2008 CCHS, where
self-report obesity prevalence in adults (18+) was found to
underestimate measured prevalence by 8.8% [2]. This value
is higher than Canada-wide estimates of 7.6% for men and
7.2% for women aged 18–79, measured from the same data
[63]. A previous Canadian study found that self-report bias
had increased from 4% in 1986–1992 to 8% in 2005 (for
adults aged 18–74 years), suggesting that self-report bias
was increasing with time in Canadian survey data
[62]. However a subsequent study did not detect a
statistically significant change between 2005 and 2008
estimates [63]. Data taken from disparate Canadian
surveys [65] suggest that the magnitude of self-report
bias has at least been maintained since 2008. In light
of the bias attributable to self-report BMI, the results
of the current projection analysis should be interpreted as
conservative underestimates of the actual underlying mea-
sured BMI trends. Overall, projection results indicate a
continual and alarming rise in future self-report obesity
that almost certainly reflects higher absolute levels and
greater increases in actual measured obesity.
Strengths of the current analysis
Within the framework of the chosen scenarios, the current
projection analyses have many strengths. These include
historical time series constructed from very large datasets
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surveys and sampling from a total of 203,951 individuals.
The use of weighted compositional regression to model
and project time trends is considered to be the most rigor-
ous regression-based approach to fit time series of multi-
category prevalence, and includes a weighting matrix that
accounts for variance heterogeneity in the surveys as well
as the covariances between BMI categories. Projection re-
sults show goodness of fit to clear and pronounced trends
in the historical data, while prediction intervals and sensi-
tivity analyses show that the results are statistically stable
and robust.
Conclusions
This study represents the first long-range projection analysis
of the future obesity prevalence and numbers of individuals
for the province of Quebec. Obesity prevalence is projected
to continue rising over the next 18 years should past trends
continue, reflecting a population BMI distribution that con-
tinues to shift to the right, toward higher values. Thus obes-
ity is expected to continue to be a priority for public health
policy and programs. Three secondary analyses have been
presented that further illustrate the utility and pertinence of
projection analyses to public health planning: (1) Decom-
position of projected trends shows that increases in total
prevalence and numbers of obesity in Quebec adults is pri-
marily an ‘epidemiologic’ rather than ‘demographic’ effect
and thus potentially amenable to public health interventions
acting on the population BMI distribution, (2) Assessments
of hypothetical obesity targets planned for 2020 illustrate
the necessity of using projected rather than current preva-
lence levels to estimate the difficulty of achieving future
targets, (3) Estimation of the projected impact on type 2
diabetes prevalence shows that while population aging is
the principal driving force, a substantial component of the
anticipated increase in type 2 diabetes prevalence and
numbers of cases is potentially amenable to intervention.
Further continued dialogue with public health planners
may lead to more refined models tailored to answer spe-
cific hypotheses or questions concerning public health
challenges associated with obesity, such as the assessment
of the impact of specific interventions or programs. More
generally, it is hoped that this work will encourage and
promote awareness and use of projections as a relevant
and useful tool for public health planning.
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